{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:34:15Z","timestamp":1789144455517,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00535-019-01551-3","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T09:52:02Z","timestamp":1549014722000},"page":"549-557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Serum aldo\u2013keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis"],"prefix":"10.1007","volume":"54","author":[{"given":"Masataka","family":"Kanno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Horii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Takatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Shimakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eishiro","family":"Mizukoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"key":"1551_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","volume":"20","author":"M Sayiner","year":"2016","unstructured":"Sayiner M, Koenig A, Henry L, et al. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the World. Clin Liver Dis. 2016;20:205\u201314.","journal-title":"Clin Liver Dis"},{"key":"1551_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology"},{"key":"1551_CR3","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52:1836\u201346.","journal-title":"Hepatology"},{"key":"1551_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00535-017-1355-9","volume":"53","author":"T Okanoue","year":"2018","unstructured":"Okanoue T, Ebise H, Kai T, et al. A simple scoring system using type IV collagen 7S and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis. J Gastroenterol. 2018;53:129\u201339.","journal-title":"J Gastroenterol"},{"key":"1551_CR5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s00535-014-1007-2","volume":"50","author":"M Abe","year":"2015","unstructured":"Abe M, Miyake T, Kuno A, et al. Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. J Gastroenterol. 2015;50:776\u201384.","journal-title":"J Gastroenterol"},{"key":"1551_CR6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s00535-017-1386-2","volume":"53","author":"K Kawaguchi","year":"2018","unstructured":"Kawaguchi K, Honda M, Ohta H, et al. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis B. J Gastroenterol. 2018;53:740\u201351.","journal-title":"J Gastroenterol"},{"key":"1551_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/hepr.13054","volume":"48","author":"M Kawanaka","year":"2018","unstructured":"Kawanaka M, Tomiyama Y, Hyogo H, et al. Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts the development of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. Hepatol Res. 2018;48:521\u20138.","journal-title":"Hepatol Res."},{"key":"1551_CR8","doi-asserted-by":"publisher","first-page":"11429","DOI":"10.1074\/jbc.273.19.11429","volume":"273","author":"D Cao","year":"1998","unstructured":"Cao D, Fan ST, Chung SS. Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem. 1998;273:11429\u201335.","journal-title":"J Biol Chem"},{"key":"1551_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jhep.2009.11.005","volume":"52","author":"S Heringlake","year":"2010","unstructured":"Heringlake S, Hofdmann M, Fiebeler A, et al. Identification and expression analysis of the aldo-ketoreductase 1-B10 gene in primary malignant liver tumours. J Hepatol. 2010;52:220\u20137.","journal-title":"J Hepatol"},{"key":"1551_CR10","doi-asserted-by":"publisher","first-page":"e46584","DOI":"10.1371\/journal.pone.0046584","volume":"7","author":"J Starmann","year":"2012","unstructured":"Starmann J, Falth M, Spindelbock W, et al. Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis. PLoS One. 2012;7:e46584.","journal-title":"PLoS One"},{"key":"1551_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-230X-12-2","volume":"12","author":"Y Sumida","year":"2012","unstructured":"Sumida Y, Yoneda M, Hyogo H, et al. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC Gastroenterol. 2012;12:2.","journal-title":"BMC Gastroenterol"},{"key":"1551_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"1551_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ccr.2011.08.024","volume":"20","author":"A Ooi","year":"2011","unstructured":"Ooi A, Wong JC, Petillo D, et al. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell. 2011;20:511\u201323.","journal-title":"Cancer Cell"},{"key":"1551_CR14","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1158\/1078-0432.CCR-04-1238","volume":"11","author":"S Fukumoto","year":"2005","unstructured":"Fukumoto S, Yamauchi N, Moriguchi H, et al. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers\u2019 non-small cell lung carcinomas. Clin Cancer Res. 2005;11:1776\u201385.","journal-title":"Clin Cancer Res"},{"key":"1551_CR15","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/modpathol.2011.191","volume":"25","author":"YT Chung","year":"2012","unstructured":"Chung YT, Matkowskyj KA, Li H, et al. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma. Mod Pathol. 2012;25:758\u201366.","journal-title":"Mod Pathol"},{"key":"1551_CR16","doi-asserted-by":"publisher","first-page":"E862","DOI":"10.1002\/ijc.27618","volume":"131","author":"J Ma","year":"2012","unstructured":"Ma J, Luo DX, Huang C, et al. AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker. Int J Cancer. 2012;131:E862\u201371.","journal-title":"Int J Cancer"},{"issue":"389\u201397","key":"1551_CR17","first-page":"e10","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(389\u201397):e10.","journal-title":"Gastroenterology"},{"key":"1551_CR18","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461\u20135.","journal-title":"Nat Genet"},{"key":"1551_CR19","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1161\/01.ATV.0000077401.36885.BB","volume":"23","author":"MC Alessi","year":"2003","unstructured":"Alessi MC, Bastelica D, Mavri A, et al. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler Thromb Vasc Biol. 2003;23:1262\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1551_CR20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/hep.22063","volume":"47","author":"M Charlton","year":"2008","unstructured":"Charlton M, Angulo P, Chalasani N, et al. Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology. 2008;47:484\u201392.","journal-title":"Hepatology"},{"key":"1551_CR21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846\u201354.","journal-title":"Hepatology"},{"key":"1551_CR22","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00535-012-0704-y","volume":"48","author":"M Yoneda","year":"2013","unstructured":"Yoneda M, Imajo K, Eguchi Y, et al. Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels. J Gastroenterol. 2013;48:1051\u201360.","journal-title":"J Gastroenterol"},{"key":"1551_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00535-010-0305-6","volume":"46","author":"Y Sumida","year":"2011","unstructured":"Sumida Y, Yoneda M, Hyogo H, et al. A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease. J Gastroenterol. 2011;46:257\u201368.","journal-title":"J Gastroenterol"},{"key":"1551_CR24","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gut.2007.146019","volume":"57","author":"SA Harrison","year":"2008","unstructured":"Harrison SA, Oliver D, Arnold HL, et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57:1441\u20137.","journal-title":"Gut"},{"key":"1551_CR25","doi-asserted-by":"publisher","first-page":"23279","DOI":"10.1038\/srep23279","volume":"6","author":"C Xu","year":"2016","unstructured":"Xu C, Chen Y, Xu L, et al. Serum complement C3 levels are associated with nonalcoholic fatty liver disease independently of metabolic features in Chinese population. Sci Rep. 2016;6:23279.","journal-title":"Sci Rep"},{"key":"1551_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30163","author":"SJ Daniels","year":"2018","unstructured":"Daniels SJ, Leeming DJ, Eslam M, et al. ADAPT: an algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis. Hepatology. 2018. \n                    https:\/\/doi.org\/10.1002\/hep.30163\n                    \n                  .","journal-title":"Hepatology"},{"key":"1551_CR27","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/hepr.13226","volume":"48","author":"Y Itoh","year":"2018","unstructured":"Itoh Y, Seko Y, Shima T, et al. Accuracy of non-invasive scoring systems for diagnosing non-alcoholic steatohepatitis-related fibrosis: multicenter validation study. Hepatol Res. 2018;48:1099\u2013107.","journal-title":"Hepatol Res"},{"key":"1551_CR28","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467\u201374.","journal-title":"Am J Gastroenterol"},{"key":"1551_CR29","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/hepr.12662","volume":"46","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Enomoto H, Iwata Y, et al. Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level in non-alcoholic steatohepatitis. Hepatol Res. 2016;46:1194\u2013202.","journal-title":"Hepatol Res."},{"key":"1551_CR30","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1007\/s00535-018-1474-y","volume":"53","author":"H Ishiba","year":"2018","unstructured":"Ishiba H, Sumida Y, Tanaka S, et al. The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study. J Gastroenterol. 2018;53:1216\u201324.","journal-title":"J Gastroenterol"},{"key":"1551_CR31","doi-asserted-by":"publisher","first-page":"36733","DOI":"10.1074\/jbc.M113.514877","volume":"288","author":"D Luo","year":"2013","unstructured":"Luo D, Bu Y, Ma J, et al. Heat shock protein 90-alpha mediates aldo-keto reductase 1B10 (AKR1B10) protein secretion through secretory lysosomes. J Biol Chem. 2013;288:36733\u201340.","journal-title":"J Biol Chem"},{"key":"1551_CR32","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00535-017-1425-z","volume":"53","author":"K Shirabe","year":"2018","unstructured":"Shirabe K, Bekki Y, Gantumur D, et al. Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis. J Gastroenterol. 2018;53:819\u201326.","journal-title":"J Gastroenterol"},{"key":"1551_CR33","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1586\/14789450.2015.1084874","volume":"12","author":"H Narimatsu","year":"2015","unstructured":"Narimatsu H. Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis\/cirrhosis diagnostics. Expert Rev Proteom. 2015;12:683\u201393.","journal-title":"Expert Rev Proteom"},{"key":"1551_CR34","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/hep.27305","volume":"60","author":"K Yamasaki","year":"2014","unstructured":"Yamasaki K, Tateyama M, Abiru S, et al. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology. 2014;60:1563\u201370.","journal-title":"Hepatology"},{"key":"1551_CR35","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ajg.2015.118","volume":"110","author":"T Umemura","year":"2015","unstructured":"Umemura T, Joshita S, Sekiguchi T, et al. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis. Am J Gastroenterol. 2015;110:857\u201364.","journal-title":"Am J Gastroenterol"},{"key":"1551_CR36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/hepr.12595","volume":"46","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Enomoto H, Iwata Y, et al. Impact of serum Wisteria floribunda agglutinin positive Mac-2-binding protein and serum interferon-gamma-inducible protein-10 in primary biliary cirrhosis. Hepatol Res. 2016;46:575\u201383.","journal-title":"Hepatol Res"},{"key":"1551_CR37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/1751-2980.12596","volume":"19","author":"WP Xu","year":"2018","unstructured":"Xu WP, Wang ZR, Zou X, et al. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein evaluates liver function and predicts prognosis in liver cirrhosis. J Dig Dis. 2018;19:242\u201353.","journal-title":"J Dig Dis."},{"key":"1551_CR38","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1111\/jgh.13802","volume":"32","author":"K Ito","year":"2017","unstructured":"Ito K, Murotani K, Nakade Y, et al. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels and liver fibrosis: a meta-analysis. J Gastroenterol Hepatol. 2017;32:1922\u201330.","journal-title":"J Gastroenterol Hepatol"},{"key":"1551_CR39","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.jhep.2018.05.019","volume":"69","author":"S Petta","year":"2018","unstructured":"Petta S, Sebastiani G, Bugianesi E, et al. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis. J Hepatol. 2018;69:878\u201385.","journal-title":"J Hepatol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-019-01551-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01551-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01551-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:35:46Z","timestamp":1580517346000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-019-01551-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1551"],"URL":"https:\/\/doi.org\/10.1007\/s00535-019-01551-3","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,1]]},"assertion":[{"value":"31 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author(s) declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}